Does DABRAFENIB Cause Lung neoplasm malignant? 84 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 84 reports of Lung neoplasm malignant have been filed in association with DABRAFENIB (Tafinlar). This represents 0.4% of all adverse event reports for DABRAFENIB.
84
Reports of Lung neoplasm malignant with DABRAFENIB
0.4%
of all DABRAFENIB reports
29
Deaths
17
Hospitalizations
How Dangerous Is Lung neoplasm malignant From DABRAFENIB?
Of the 84 reports, 29 (34.5%) resulted in death, 17 (20.2%) required hospitalization, and 3 (3.6%) were considered life-threatening.
Is Lung neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DABRAFENIB. However, 84 reports have been filed with the FAERS database.
What Other Side Effects Does DABRAFENIB Cause?
Pyrexia (3,788)
Death (2,740)
Malignant neoplasm progression (1,667)
Fatigue (1,328)
Nausea (1,300)
Chills (1,235)
Rash (1,078)
Vomiting (907)
Diarrhoea (901)
Headache (697)
What Other Drugs Cause Lung neoplasm malignant?
RANITIDINE (15,214)
ADALIMUMAB (698)
TIOTROPIUM (637)
ETANERCEPT (612)
METHOTREXATE (522)
CLOZAPINE (440)
APIXABAN (411)
ALBUTEROL (403)
INFLIXIMAB (379)
BUDESONIDE\FORMOTEROL (353)
Which DABRAFENIB Alternatives Have Lower Lung neoplasm malignant Risk?
DABRAFENIB vs DABRAFENIB\TRAMETINIB
DABRAFENIB vs DACARBAZINE
DABRAFENIB vs DACLATASVIR
DABRAFENIB vs DACLIZUMAB
DABRAFENIB vs DACOMITINIB